Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 284

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 284
---
,814,635 |     |                   5.33 |

There was $ 748,494unrecognized stock-based compensation expense as of September 30, 2025, which will be recognized over a period of approximately 2.18years.

Warrants

The following is a summary of the Company’s warrant activity for the nine months ended September 30, 2025:

Schedule of Warrant Activity

|                          |     | Number    
 of Shares |            |   |     | Weighted       
 Average        
 Exercise Price 
 per            
 Share          |      |     | Weighted       
 Average        
 Remaining Life 
 (Years)        |      |
|:-------------------------|:----|:----------|-----------:|:--|:----|:---------------|-----:|:----|:---------------|-----:|
| Outstanding              
 as of December 31, 2024  |     |           |  1,359,375 |   |     | $              | 0.80 |     |                | 0.93 |
| Exercised                |     |           | (1,359,375 | ) |     |                | 0.80 |     |                |    - |
| Forfeited                |     |           |          - |   |     |                |    - |     |                |    - |
| Outstanding              
 as of September 30, 2025 |     |           |          - |   |     | $              |    - |     |                |    - |

| F-39 |

JUPITER NEUROSCIENCES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 6 – Stockholders’ Equity, continued

Effective June 22, 2025, the Company entered into an amendment with a warrant holder for a warrant to purchase 109,376shares of Common Stock. The amendment extended the warrant’s exercise period through August 31, 2025, and clarified the exercise mechanism applicable to the warrant. The effects of the warrant modification were de minimis.

On July 16, 2025 the Company entered into an amendment with a warrant holder who holds 1,249,999warrants that clarified the exercise mechanisms. Concurrently with the amendment, the warrant holder exercised the warrants via a cashless exercise and received 913,299shares of Common Stock. Pursuant to the amendment, the Company agreed to issue the warrant holder 86,700shares of Common